Amneal to Report Fourth Quarter and Full Year 2019 Results on February 26, 2020
January 24 2020 - 6:59AM
Business Wire
Amneal Pharmaceuticals, Inc. (NYSE:AMRX) announced today that
the Company will release its fourth quarter and full year 2019
financial results on Wednesday, February 26, 2020, prior to the
open of the U.S. financial markets. The Company will host a
conference call and live webcast with the investment community at
8:30 a.m. Eastern Time on February 26, 2020.
The financial results and live webcast will be accessible
through the Investor Relations section of the Company's Web site at
https://investors.amneal.com. The webcast can also be accessed at
the following URL:
https://event.on24.com/wcc/r/2151439/4C4EB837C71C6C5471232024C3FDFD00.
To access the call through a conference line, dial
1-844-746-0741 (in the U.S.) and 1-412-317-5273 (international
callers).
A replay of the conference call will be available shortly after
the live event until March 4, 2020. To access the replay, dial
1-877-344-7529 (in the U.S.) or 1-412-317-0088 (international
callers). The access code for the replay is 10138831.
About Amneal
Amneal Pharmaceuticals, Inc. (NYSE:AMRX), headquartered in
Bridgewater, NJ, is a fully-integrated pharmaceutical company
focused on the development, manufacture and distribution of generic
and specialty drug products. The Company has manufacturing
operations in North America, Asia, and Europe, working together to
bring high-quality medicines to patients primarily within the
United States.
Amneal has an extensive portfolio of more than 225 marketed
commercial products and is expanding its portfolio to include
complex dosage forms, including biosimilars, in a broad range of
therapeutic areas. The Company also markets a portfolio of branded
pharmaceutical products through its Specialty segment focused
principally on central nervous system and endocrine disorders. For
more information, visit www.amneal.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200124005059/en/
Todd Branning Chief Financial Officer (908) 280-6019
www.amneal.com
Amneal Pharmaceuticals (NYSE:AMRX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Amneal Pharmaceuticals (NYSE:AMRX)
Historical Stock Chart
From Apr 2023 to Apr 2024